Definitely,lets all call IR and tell her to start calling all the other firms covering us---- Someones head better roll for this.Between the news yesterday and this AM,something really smells bad here.
Remember, they said in a prior call that they have weekly calls with the FDA regarding NTM. It seems more than a little preposterous that their phase 2 design was insufficient when the FDA was in the thick of it.
Someone is vacuuming up shares right above 17. For every share sold someone had to buy. Looks like 28,000 shares sold and 28,000 shares bought right now. Institutions are over 87% of shares and are unlikely to sell but, if history is an indication, likely to add. Look for reiterations this week from other analysts.